Aberrant maspin expression in gallbladder epithelium is associated with intestinal metaplasia in patients with cholelithiasis

Journal of Clinical Pathology

Volumn 59, Issue 3, 2006, Pages 328-330

  Maesawa, C ^a   Ogasawara, S ^a   Yashima Abo, A ^a   Kimura, T ^a   Kotani, K ^a   Masuda, S ^a   Nagata, Y ^a   Iwaya, T ^a   Suzuki, K ^a   Oyake, T ^a   Akiyama, Y ^a   Kawamura, H ^a   Masuda, T ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SUSCEPTIBILITY; CHOLELITHIASIS; CONTROLLED STUDY; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER;

ADULT; CASE-CONTROL STUDIES; CHOLELITHIASIS; DISEASE PROGRESSION; ENDOTHELIUM; FEMALE; GALLBLADDER; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; METAPLASIA; MIDDLE AGED; SERPINS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33644757019     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.027284     Document Type: Article

References (15)

1. Zou Z, Anisowicz A, Hendrix MJ, et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 1994;263:526-9.
2. Sood AK, Fletcher MS, Gruman LM, et al. The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 2002;8:2924-32.
3. Maass N, Hojo T, Ueding M, et al. Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 2001;7:812-17.
4. Akiyama Y, Maesawa C, Ogasawara S, et al. Cell-type-specific repression of the maspin gene is disrupted frequently by demethylation at the promoter region in gastric intestinal metaplasia and cancer cells. Am J Pathol 2003;163:1911-19.
5. Ogasawara S, Maesawa C, Yamamoto M, et al. Disruption of cell-type-specific methylation at the maspin gene promoter is frequently involved in undifferentiated thyroid cancers. Oncogene 2004;23:1117-24.
6. Futscher BW, Oshiro MM, Wozniak RJ, et al. Role for DNA methylation in the control of cell type specific maspin expression. Nat Genet 2002;31:175-9.
7. Smith SL, Watson SG, Ratschiller D, et al. Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions. Oncogene 2003;22:8677-87.
8. Fujisawa K, Maesawa C, Sato R, et al. Epigenetic status and aberrant expression of the maspin gene in human hepato-biliary tract carcinomas. Lab Invest 2004;85:214-24.
9. Fitzgerald M, Oshiro M, Holtan N, et al. Human pancreatic carcinoma cells activate maspin expression through loss of epigenetic control. Neoplasia 2003;5:427-36.
10. Kozuka S, Hachisuka K. Incidence by age and sex of intestinal metaplasia in the gallbladder. Hum Pathol 1984;15:779-84.
11. Duarte I, Llanos O, Domke H, et al. Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer 1993;72:1878-84.
12. Ishikawa A, Sasaki M, Ohira S, et al. Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis. Lab Invest 2004;84:629-38.
13. Sasaki M, Tsuneyama K, Nakanuma Y. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma. Lab Invest 2003;83:1403-13.
14. Wu XS, Akiyama Y, Igari T, et al. Expression of homeodomain protein CDX2 in gallbladder carcinomas. J Cancer Res Clin Oncol 2005;131:271-8.
15. Yuasa Y, Nagasaki H, Akiyama Y, et al. Relationship between CDX2 gene methylation and dietary factors in gastric cancer patients. Carcinogenesis 2005;26:193-200.